STOCK TITAN

Vanguard disaggregates holdings, reports 0 CBT shares (NYSE: CBT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cabot Corp: The Vanguard Group filed an amendment to its Schedule 13G to report 0 shares of Cabot Corp common stock, representing 0% of the class as disclosed in the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, which caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; reports no beneficial ownership in Cabot.

The amendment states 0 shares beneficially owned and 0% of the class as of the filing. It attributes the change to an internal realignment on January 12, 2026 and cites SEC Release No. 34-39538 for disaggregated reporting by subsidiaries.

Cash‑flow treatment and trading intent are not provided in the excerpt. Subsequent filings from Vanguard or the listed subsidiaries may show separate positions after the realignment.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Vanguard's Schedule 13G/A say about CBT holdings?

The amendment reports 0 shares of Cabot Corp common stock, representing 0% of the class. It states this reporting follows an internal realignment and disaggregation of Vanguard subsidiaries under SEC Release No. 34-39538.

Does the filing indicate Vanguard sold CBT shares?

No sale or transaction is stated; the amendment reports a beneficial ownership of 0 shares. The change is attributed to an internal realignment and separate reporting by Vanguard subsidiaries, not an explicitly described sale.

When did Vanguard's internal realignment occur?

The amendment cites an internal realignment on January 12, 2026. It references SEC Release No. 34-39538 as the basis for subsidiaries to report beneficial ownership separately following that realignment.

Who signed the Schedule 13G/A for Vanguard regarding CBT?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/26/2026. The report lists The Vanguard Group as the filer and provides Vanguard's Malvern, PA address.

Does the amendment show any percentage over 5% for CBT?

No. The report explicitly states ownership of 0% and includes a statement that no other person's interest reported exceeds 5% of the class in the disclosed holdings.
Cabot

NYSE:CBT

View CBT Stock Overview

CBT Rankings

CBT Latest News

CBT Latest SEC Filings

CBT Stock Data

3.86B
50.89M
Specialty Chemicals
Miscellaneous Chemical Products
Link
United States
BOSTON